Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

H C Herrmann

Showing results (71-80 of 78) with videos related to

Pageof 8
Sort By:
You have reached the last page of results.This site can display upto 78 results.
The American Journal of Cardiology|January 15, 1990
Hemodynamic and renal effects of atrial natriuretic peptide in congestive heart failureM A Fifer, C R Molina, A C Quiroz, et al.
Annals of Internal Medicine|February 1, 1997
Cardiac Whipple disease: identification of Whipple bacillus by electron microscopy of a patient before deathF E Silvestry, B Kim, B J Pollack, et al.
Journal of the American College of Cardiology|March 1, 1996
Randomized, double-blind, placebo-controlled dose-ranging study of tirofiban (MK-383) platelet IIb/IIIa blockade in high risk patients undergoing coronary angioplastyD J Kereiakes, N S Kleiman, J Ambrose, et al.
The American Journal of Cardiology|June 17, 2000
Predictors of clinical outcome following percutaneous intervention for in-stent restenosisB D Klugherz, N F Meneveau, D M Kolansky, et al.
Journal of the American College of Cardiology|November 18, 2000
Facilitation of early percutaneous coronary intervention after reteplase with or without abciximab in acute myocardial infarction: results from the SPEED (GUSTO-4 Pilot) TrialH C Herrmann, D J Moliterno, E M Ohman, et al.
The New England Journal of Medicine|June 23, 2001
Comparison of two platelet glycoprotein IIb/IIIa inhibitors, tirofiban and abciximab, for the prevention of ischemic events with percutaneous coronary revascularizationE J Topol, D J Moliterno, H C Herrmann, et al.
Circulation|September 29, 1999
ACC/AHA guidelines for coronary artery bypass graft surgery: executive summary and recommendations : A report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Committee to revise the 1991 guidelines for coronary artery bypass graft surgery)K A Eagle, R A Guyton, R Davidoff, et al.
Journal of the American College of Cardiology|October 16, 1999
ACC/AHA Guidelines for Coronary Artery Bypass Graft Surgery: A Report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Committee to Revise the 1991 Guidelines for Coronary Artery Bypass Graft Surgery). American College of Cardiology/American Heart AssociationK A Eagle, R A Guyton, R Davidoff, et al.
Pageof 8

Showing results (71-80 of 78) with videos related to

Sort By:
Pageof 8
You have reached the last page of results.This site can display upto 78 results.
The American Journal of Cardiology|January 15, 1990
Hemodynamic and renal effects of atrial natriuretic peptide in congestive heart failureM A Fifer, C R Molina, A C Quiroz, et al.
Annals of Internal Medicine|February 1, 1997
Cardiac Whipple disease: identification of Whipple bacillus by electron microscopy of a patient before deathF E Silvestry, B Kim, B J Pollack, et al.
Journal of the American College of Cardiology|March 1, 1996
Randomized, double-blind, placebo-controlled dose-ranging study of tirofiban (MK-383) platelet IIb/IIIa blockade in high risk patients undergoing coronary angioplastyD J Kereiakes, N S Kleiman, J Ambrose, et al.
The American Journal of Cardiology|June 17, 2000
Predictors of clinical outcome following percutaneous intervention for in-stent restenosisB D Klugherz, N F Meneveau, D M Kolansky, et al.
Journal of the American College of Cardiology|November 18, 2000
Facilitation of early percutaneous coronary intervention after reteplase with or without abciximab in acute myocardial infarction: results from the SPEED (GUSTO-4 Pilot) TrialH C Herrmann, D J Moliterno, E M Ohman, et al.
The New England Journal of Medicine|June 23, 2001
Comparison of two platelet glycoprotein IIb/IIIa inhibitors, tirofiban and abciximab, for the prevention of ischemic events with percutaneous coronary revascularizationE J Topol, D J Moliterno, H C Herrmann, et al.
Circulation|September 29, 1999
ACC/AHA guidelines for coronary artery bypass graft surgery: executive summary and recommendations : A report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Committee to revise the 1991 guidelines for coronary artery bypass graft surgery)K A Eagle, R A Guyton, R Davidoff, et al.
Journal of the American College of Cardiology|October 16, 1999
ACC/AHA Guidelines for Coronary Artery Bypass Graft Surgery: A Report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Committee to Revise the 1991 Guidelines for Coronary Artery Bypass Graft Surgery). American College of Cardiology/American Heart AssociationK A Eagle, R A Guyton, R Davidoff, et al.
Pageof 8